iPS Bio, Inc.
PrivateLast Round
Series A
May 17, 2021
Est. Valuation
$21.4M
Total Funding Raised
$7.13M
Company Overview
iPS Bio, Inc. is a biotechnology company that develops induced pluripotent stem cell (iPSC)-based cell therapies and drug discovery platforms for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iPS Bio, Inc. Comparables
Compare iPS Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orizuru Therapeutics, Inc. | 76% | |
| Aspen Neuroscience | 70% | |
| Bayer AG | 70% | |
iPS Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 17, 2021 | ||||
| Grant | Jun 1, 2020 |
iPS Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TIPS (Tech Incubator Program for Startup) | Grant |
| Schmidt | Seed |
| Kolon Investment | Series A |
| LSK Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2021
$7.1M round led by Kolon Investment and LSK Investment.
- Jun 1, 2020
Received grant from TIPS (Tech Incubator Program for Startup).
iPS Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iPS Bio, Inc.'s valuation, stock price, and market status.